SCHEMBL18748945

SCHEMBL18748945

CCc1cc(C)ccc1OCc1c(CC)cccc1NC(=S)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 5/20 0.40
MEN1 O00255 3/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PTGER1 P34995 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38
POLB P06746 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.35
CRHBP P24387 1/20 0.35
MAPK1 P28482 1/20 0.35
CRHR2 Q13324 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18748906 0.94 L3MBTL1 (0.39) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18748903 0.92 KDM4E (0.38) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18748975 0.92 MRGPRX4 (0.43) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18748902 0.90 MRGPRX4 (0.45) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18749096 0.90 CYP1A2 (0.38) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18749045 0.90 ALDH1A1 (0.38) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18748897 0.90 MRGPRX4 (0.45) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18748881 0.90 SMN1; SMN2 (0.42) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18749048 0.90 GAA (0.41) KDM4EL3MBTL1KMT2AMEN1TSHR
SCHEMBL18749051 0.90 KCNMA1 (0.39) KDM4EL3MBTL1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 KDM4E 619/4885L3MBTL1 35/4885KMT2A 705/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 KDM4E 1043/4885L3MBTL1 77/4885KMT2A 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.